National Vision PE ratio EYE

Share price divided by earnings per share over the last twelve months, since 2018.

Today, Oct 23, 2026: 30.6×
8-year median: 53.3×
Against its 8-year history: 19th; percentile: 0 is its lowest day, 100 its highest
8-year range: 20.3× to 334×
Peer median: 34.4×

National Vision's PE ratio is 30.6× as of Oct 23, 2026: a share price of $18.67 against $0.61 of earnings per share over the last twelve months.

That is below its 8-year median of 53.3×, lower than on 81% of days in the last 8 years.

Over that time it ranged from 20.3× in Jun 2022 to 334× in Jan 2020.

The median for 10 medical instruments and supplies stocks of a similar size is 34.4×.

PE ratio over time

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	30.6×	26.9×	75.4×
2025	n/m a value too high to mean anything
2024	n/m a value too high to mean anything
2023	53.3×	35.4×	70.5×
2022	57.9×	20.3×	61.1×
2021	27.1×	26.2×	125×
2020	103×	35.1×	334×
2019	301×	29.2×	301×
2018	30.5×	27.8×	50.2×

Against its peers

Companies in Medical - Instruments & Supplies nearest National Vision's size, closest first, today.

Company	PE ratio
EYENational Vision	30.6×
CDRECadre	37.0×
BVSBioventus	19.4×
STAAStaar Surgical	323×
LMATLemaitre Vascular	29.6×
IRMDIradimed	47.9×
INSPInspire Medical Systems	15.4×
UFPTUFP Technologies	31.9×
ATRCAtriCure	281×
MOVMovado	17.5×
WRBYWarby Parker	370×
Peer median	34.4×

Where National Vision ranks

What the PE ratio tells you

Share price divided by earnings per share over the last twelve months. It is the price tag on a dollar of profit: 20× means you pay $20 for $1 of yearly earnings.

Blank while earnings are negative. A very low PE can mean the market expects profits to fall, so read it with growth and the company's own history.

More on National Vision

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.